Lynne Powell
Direttore/Membro del Consiglio presso BIORA THERAPEUTICS, INC.
Patrimonio netto: 3 488 $ in data 30/04/2024
Profilo
Lynne M.
Powell is currently the Chief Executive Officer & Director at Tavanta Therapeutics, Inc. and an Independent Director at Biora Therapeutics, Inc. She was previously the Chief Executive Officer & Director at Druggability Technologies Holdings Ltd., Chief Commercial Officer & Senior Vice President at BioCryst Pharmaceuticals, Inc., and Senior VP-North American Commercial Operations at CSL Behring LLC.
Powell holds an MBA from Monash University and the University of Warwick, and an undergraduate degree from the University of East London.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIORA THERAPEUTICS, INC.
0.02% | 01/03/2024 | 5 746 ( 0.02% ) | 3 488 $ | 30/04/2024 |
Posizioni attive di Lynne Powell
| Società | Posizione | Inizio |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/02/2019 |
Tavanta Therapeutics, Inc.
 Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Amministratore Delegato | 01/09/2019 |
Precedenti posizioni note di Lynne Powell
| Società | Posizione | Fine |
|---|---|---|
Druggability Technologies Holdings Ltd.
 Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Amministratore Delegato | 01/10/2019 |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2019 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/10/2014 |
Formazione di Lynne Powell
| Monash University | Masters Business Admin |
| University of Warwick | Masters Business Admin |
| University of East London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| BIORA THERAPEUTICS, INC. | Health Services |
| Aziende private | 3 |
|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
Druggability Technologies Holdings Ltd.
Druggability Technologies Holdings Ltd. BiotechnologyHealth Technology Druggability Technologies Holdings Ltd., part of DRGT Holdco (Malta) Ltd., is a company headquartered in Dublin, Ireland. The firm develops proprietary drugs. | Health Technology |
Tavanta Therapeutics, Inc.
Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tavanta Therapeutics, Inc. operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs. The company is based in King of Prussia, PA and has subsidiaries in Hungary. Lynne M. Powell has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Lynne Powell
